DNMT3A and hematopoietic and lymphoid cell neoplasm: Jaiswal et al. reported that DNMT3A mutation were the most frequent mutations observed with aging and that patients with DNMT3A mutations had a 10- to 50-fold higher propensity for developing hematologic cancer [24].